Liew Danny, Audehm Ralph G, Haikerwal Deepak, Piazza Peter, Neville A Munro, Lim Kevin, Parsons Richard W, Sindone Andrew P
School of Public Health and Preventive Medicine, Monash University, 553 St Kilda Rd, Melbourne, VIC, 3004, Australia.
Department of General Practice, University of Melbourne, Melbourne, VIC, Australia.
ESC Heart Fail. 2020 Dec;7(6):3871-3880. doi: 10.1002/ehf2.12979. Epub 2020 Sep 9.
At present, there is no robust information on the prevalence and incidence of heart failure (HF) in the general Australian community. The present study of primary care data sought to estimate the prevalence and incidence of HF in the community and to describe the demographic and clinical profile of Australians with HF.
We undertook a retrospective cohort study based on analysis of anonymized medical records of adult patients cared for at 43 Australian general practices between 1 July 2013 and 30 June 2018. Data were extracted from coded and uncoded fields in electronic medical records. The prevalence and annual incidence of HF were calculated, along with 95% confidence intervals, using the 'active' population of people who were regular attenders at the practices. Age-standardized estimates were also derived using the 2017 Australian population as reference. The mean age of the population with HF was 69.8 years, 50.6% were female, and mean body mass index was 31.2 kg/m . The age-standardized prevalence was 2.199% [95% confidence interval (CI): 2.168-2.23%], and the age-standardized annual incidence was 0.348% (95% CI: 0.342-0.354%). These estimates accord with almost 420 000 people living with HF in Australia in 2017, and >66 000 new cases of HF occurring that year. Only 18.9% of patients with definite HF had this formally captured as a 'diagnosis' in their medical record. HF was more frequent among those of lower socio-economic status.
HF is common in Australia. The majority of HF patients do not have this diagnosis optimally noted in their primary care medical records.
目前，关于澳大利亚普通社区中心力衰竭（HF）的患病率和发病率，尚无可靠信息。本项针对初级保健数据的研究旨在估算社区中HF的患病率和发病率，并描述澳大利亚HF患者的人口统计学和临床特征。
我们进行了一项回顾性队列研究，基于对2013年7月1日至2018年6月30日期间在澳大利亚43家普通诊所接受治疗的成年患者匿名医疗记录的分析。数据从电子病历中的编码和未编码字段中提取。使用诊所的定期就诊“活跃”人群计算HF的患病率和年发病率以及95%置信区间。还以2017年澳大利亚人口为参考得出年龄标准化估计值。HF患者的平均年龄为69.8岁，50.6%为女性，平均体重指数为31.2kg/m 。年龄标准化患病率为2.199%[95%置信区间（CI）：2.168 - 2.23%]，年龄标准化年发病率为0.348%（95%CI：0.342 - 0.354%）。这些估计表明，2017年澳大利亚有近42万人患有HF，同年有超过6.6万例新的HF病例。在确诊为HF的患者中，只有18.9%在其病历中被正式记录为“诊断”。社会经济地位较低者中HF更为常见。
HF在澳大利亚很常见。大多数HF患者在其初级保健病历中并未得到最佳诊断记录。
